India's pharmaceutical and medtech sectors are transforming through initiatives like the Production Linked Incentive (PLI) Scheme and the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). These aim to boost domestic manufacturing, reduce import dependency, and improve access to affordable healthcare. Significant FDI inflows indicate growing investor confidence.
